Investing

Investment analysis, share recommendations, and market insights.

Premium

Three promising medical device makers

The human healthcare industry can be a frustrating place to invest but here are three examples on the ASX that are making a good fist of establishing their respective devices in world markets.

James Dunn · September 15, 2025
Premium

Is Wesfarmers too expensive?

Wesfarmers (WES) has climbed all year, trading as high as $95.17 before the release of its full year result. Now the question is: Is it too expensive and a sell? Here’s what I think.

Paul Rickard · September 8, 2025

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.